Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


Vitiligo and the melanocyte reservoir.

Falabella R.

Indian J Dermatol. 2009;54(4):313-8. doi: 10.4103/0019-5154.57604.


Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.

Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH.

J Immunol. 2010 Feb 15;184(4):1909-17. doi: 10.4049/jimmunol.0902778. Epub 2010 Jan 18.


Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.

van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM.

J Invest Dermatol. 2009 Sep;129(9):2220-32. doi: 10.1038/jid.2009.32. Epub 2009 Feb 26.


Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.

Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, Abel L, Jouanguy E, Casanova JL.

Immunol Rev. 2008 Dec;226:29-40. doi: 10.1111/j.1600-065X.2008.00698.x. Review.


Clinical practice. Vitiligo.

Taïeb A, Picardo M.

N Engl J Med. 2009 Jan 8;360(2):160-9. doi: 10.1056/NEJMcp0804388. Review. No abstract available.


Orchestrating the orchestrators: chemokines in control of T cell traffic.

Bromley SK, Mempel TR, Luster AD.

Nat Immunol. 2008 Sep;9(9):970-80. doi: 10.1038/ni.f.213. Review.


Interstitial leukocyte migration and immune function.

Friedl P, Weigelin B.

Nat Immunol. 2008 Sep;9(9):960-9. doi: 10.1038/ni.f.212. Review.


Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Gilhar A, Paus R, Kalish RS.

J Clin Invest. 2007 Aug;117(8):2019-27. Review.


Random migration precedes stable target cell interactions of tumor-infiltrating T cells.

Mrass P, Takano H, Ng LG, Daxini S, Lasaro MO, Iparraguirre A, Cavanagh LL, von Andrian UH, Ertl HC, Haydon PG, Weninger W.

J Exp Med. 2006 Nov 27;203(12):2749-61. Epub 2006 Nov 20.


Cytotoxic T cells.

Andersen MH, Schrama D, Thor Straten P, Becker JC.

J Invest Dermatol. 2006 Jan;126(1):32-41. Review.


A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection.

Suffia I, Reckling SK, Salay G, Belkaid Y.

J Immunol. 2005 May 1;174(9):5444-55.


CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, Rosenberg SA, Restifo NP.

J Immunol. 2005 Mar 1;174(5):2591-601.


Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking?

Marelli-Berg FM, Jarmin SJ.

Immunol Lett. 2004 May 15;93(2-3):109-13. Review.


Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway.

Elso CM, Roberts LJ, Smyth GK, Thomson RJ, Baldwin TM, Foote SJ, Handman E.

Genes Immun. 2004 Mar;5(2):93-100.


Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, Vyth-Dreese FA, Dellemijn TA, Antony PA, Spiess PJ, Palmer DC, Heimann DM, Klebanoff CA, Yu Z, Hwang LN, Feigenbaum L, Kruisbeek AM, Rosenberg SA, Restifo NP.

J Exp Med. 2003 Aug 18;198(4):569-80.


Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.

Wańkowicz-Kalińska A, van den Wijngaard RM, Tigges BJ, Westerhof W, Ogg GS, Cerundolo V, Storkus WJ, Das PK.

Lab Invest. 2003 May;83(5):683-95.


Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.

Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS.

J Invest Dermatol. 2001 Dec;117(6):1357-62.


High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.

Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V.

J Exp Med. 1998 Sep 21;188(6):1203-8.


gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.

Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, Tsung K, Carroll MW, Liu C, Moss B, Rosenberg SA, Restifo NP.

J Exp Med. 1998 Jul 20;188(2):277-86.


Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor.

Kunisada T, Lu SZ, Yoshida H, Nishikawa S, Nishikawa S, Mizoguchi M, Hayashi S, Tyrrell L, Williams DA, Wang X, Longley BJ.

J Exp Med. 1998 May 18;187(10):1565-73.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk